Product Launch Announcement: Sutiheal 50 (Sunitinib Malate 50mg) Capsule
We are proud to introduce Sutiheal 50 contains Sunitinib Malate 50 mg, an oral targeted anticancer therapy belonging to the multi-targeted tyrosine kinase inhibitor (TKI) class. It is indicated for the treatment of selected advanced cancers, including renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST) after failure or intolerance to imatinib, and pancreatic neuroendocrine tumors (pNET) in appropriate patients. Sutiheal 50 is manufactured to stringent pharmaceutical quality standards, ensuring consistent efficacy, safety, and reliability.
🔍 Product Overview
Generic Name: Sunitinib Malate
Strength: 50mg
Formulation: Capsules
Primary Indications:
Sutiheal 50 (Sunitinib Malate 50mg) Capsule is indicated for the treatment of:
- Advanced or metastatic renal cell carcinoma (RCC).
- Gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib therapy.
- Well-differentiated, unresectable or metastatic pancreatic neuroendocrine tumors (pNET), as appropriate.
- Use under the supervision of a qualified oncologist in accordance with approved prescribing information.
Mechanism of Action:
Sunitinib is a multi-targeted tyrosine kinase inhibitor that blocks several receptors involved in tumor growth and angiogenesis, including VEGFR, PDGFR, KIT, FLT3, and RET. By inhibiting these signaling pathways, it helps reduce tumor cell proliferation and limits the formation of new blood vessels that support tumor growth.
💡 Key Benefits
- Broad-spectrum targeted therapy for multiple advanced malignancies.
- Inhibits tumor growth and angiogenesis through multiple kinase targets.
- Convenient oral capsule for outpatient treatment.
- Clinically established efficacy in approved indications.
- Manufactured under stringent quality standards for consistent performance and reliability.
🎯 Target Audience
- Medical Oncologists
- Surgical Oncologists
- Gastrointestinal Oncologists
- Onco-Urologists
- Cancer Care Specialists
- Hospitals and Oncology Centers
- Specialty Pharmacies
🏥 Commitment to Clinical Excellence
Sutiheal 50 is developed with a commitment to advancing oncology care through high-quality targeted therapies. Manufactured in compliance with Good Manufacturing Practices (GMP), each batch undergoes rigorous quality testing to ensure safety, consistency, and reliability. Our focus is to provide healthcare professionals with trusted oncology solutions that support improved patient outcomes.
📦 Availability
Sutiheal 50 (Sunitinib Malate 50mg) capsules are available through authorized distributors and healthcare supply channels. For supply inquiries, bulk orders, or regulatory documentation, please contact our sales or distribution team.
Sutiheal 50 – Targeting Multiple Pathways. Transforming Cancer Care.
